Healthcare • Medical Devices
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.
Company profile from EODHD, stored Oct 27, 2026.
The last 4 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 11, 2026 | $29.4M | +82.1% | 60.2% | -$13.5M | -$13.2M |
| Mar 2026filed May 8, 2026 | $26.0M | +98.9% | 55.5% | -$12.3M | -$21.3M |
| Jun 2025 | $16.2M | — | 53.1% | -$7.9M | -$7.0M |
| Mar 2025 | $13.1M | — | 48.8% | -$8.6M | -$7.7M |
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Dec 31, 2025 | $74.2M | — | 56.2% | -$31.3M | -$29.8M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched ALMR. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
2,676,396 shares short
-134,542 shares (-4.8%) vs Sep 30, 2026
7.4% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
2,810,938 shares short
+688,598 shares (+32.4%) vs Sep 15, 2026
7.8% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
2,122,340 shares short
+1,159 shares (+0.1%) vs Aug 31, 2026
5.8% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
2,121,181 shares short
+45,740 shares (+2.2%) vs Aug 14, 2026
5.8% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
2,075,441 shares short
-354,563 shares (-14.6%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
2,430,004 shares short
+184,282 shares (+8.2%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind ALMR’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
No qualified split events are stored. This does not establish that the stock has never split.
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if ALMR is in your portfolio and how much it contributes.
Sign inLoading market dates
21 smart-money holders: institutions with a high Holder IQ
Sentiment: bearish
Last trade: sell 2 days ago
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 0
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
Stored recent-activity label: bearish. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
87 filers reported a long position in ALMR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
65%
of the 24.5M shares 13-F filers reported
Moves vs Q1 2026
No comparable changes
10 new
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Sands Capital Alternatives, LLC | $114.6M · 4.2M shares | 4.2M | New |
| 2 | Samsara BioCapital, LLC | $67.2M · 2.5M shares | 2.5M | New |
| 3 | T. Rowe Price Investment Management, Inc. | $59.7M · 2.2M shares | 2.2M | New |
| 4 | ARK Investment Management LLC | $37.2M · 1.4M shares | 1.4M | New |
| 5 | BRAIDWELL LP | $29.4M · 1.1M shares | 1.1M | New |
| 6 | ALLIANCEBERNSTEIN L.P. | $27.2M · 1M shares | 1M | New |
| 7 | HHLR ADVISORS, LTD. | $25.9M · 956.5K shares | 956.5K | New |
| 8 | BlackRock, Inc. | $24.7M · 911.4K shares | 911.4K | New |
| 9 | MILLENNIUM MANAGEMENT LLC | $23.5M · 865.8K shares | 865.8K | New |
| 10 | FMR LLC | $22.5M · 829.4K shares | 829.4K | New |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of ALMR file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 13, 2026 | Luo Yuling13G · passive | 6.4% |
| Aug 11, 2026 | Qiming Corporate GP VI, Ltd.13G · passive | 10.2% |
| Jul 7, 2026 | Sands Capital Life Sciences Pulse Fund II LP13D · activist · amended | 6.1% |
| Jul 2, 2026 | CIK 186295313G · passive | 7.2% |
| Apr 23, 2026 | Illumina Innovation Fund II, L.P.13D · activist | 9.6% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.